Form 4 for ORGO Organogenesis Holdings Inc.
Accepted 2023-02-17 00:00:00 ET · period of report 2023-02-15 · accession 0001062993-23-004061 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-02-17 | 2023-02-15+ | ORGO | Montecalvo Antonio S. | VP Health Policy, Contracting | F - Tax | $2.86 | -1,966 | 39.6K | -5% | -$5,619 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-02-15 | F | D | 1,249 | $2.92 | 40,302 | D | — | — | |
| 2 | Common | Class A Common Stock | 2023-02-16 | F | D | 717 | $2.75 | 39,585 | D | — | — |